Menu

Milestone Pharmaceuticals Inc. MIST

Full chart Compare
Set alert

Price alert · MIST

All alert types
0.69 USD -0.08 (-10.36%)

At closeNov 6, 2026, 7:20 AM EST

0.70 +0.01 +1.08%

Pre-market · Nov 6, 7:20 AM ET

0.6752 Day range 0.785
0.631 52-week range 3.06
YTD
-65.72%
1 year
-61.53%

Revenue & Expenses

Income Tax Benefit → Expenses: $345.00KExpenses → Selling, General & Admin: $17.27MExpenses → Research & Development: $18.11MExpenses → Other Operating Expenses: $28.54MExpenses → Other Expenses: $918.00KGross Profit → Expenses: $1.43MRevenue → Gross Profit: $1.43MRevenue → Cost of Revenue: $114.00KNet Loss → Expenses: $63.06MIncome Tax Benefit$345.00KGross Profit$1.43MNet Loss$63.06MCost of Revenue$114.00KExpenses$64.83MSelling, General & Admin$17.27MResearch & Development$18.11MOther Operating Expenses$28.54MOther Expenses$918.00KRevenue$1.55M

Latest period ending Dec 31, 2025 · select a line to chart its full history

MIST annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.55M01.00M5.00M15.00M
1.55M01.00M5.00M15.00M
-62.14M-42.10M-61.10M-59.64M-43.07M
-63.06M-41.52M-59.69M-58.39M-42.85M
-0.75-0.67-1.39-1.38-1.02
MIST annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
73.05M25.31M13.76M7.64M114.14M
113.56M75.50M75.23M74.48M119.85M
71.79M62.35M58.45M8.13M7.25M
58.38M54.80M51.77M2.49M698.00K
41.77M13.15M16.77M66.35M112.60M
MIST annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-49.04M-28.85M-46.42M-52.47M-33.22M
11.25M8.28M4.76M-57.12M70.00M
85.53M32.12M47.79M3.09M5.05M
-302.00K-33.00K-112.00K-272.00K0
47.73M11.55M6.12M-106.50M41.83M